The most comprehensive and up-to-date exploration of one of the most important religious orders in the modern worldSince its founding by Ignatius of Loyola in 1540, the Society of Jesus—more commonly known as the Jesuits—has played a critical role in the events of modern history. From the Counter-Reformation to the ascent of Francis I as the first Jesuit pope, The Jesuits presents an intimate look at one of the most important religious orders not only in t...

A history of genealogical knowledge-making strategies in the early modern world.In The Maker of Pedigrees, Markus Friedrich explores the complex and fascinating world of central European genealogy practices during the Baroque era. Drawing on archival material from a dozen European institutions, Friedrich reconstructs how knowledge about noble families was created, authenticated, circulated, and published. Jakob Wilhelm Imhoff, a wealthy and well-connected ...

The Birth of the Archive traces the history of archives from their emergence in the Late Middle Ages through the Early Modern Period, and vividly shows how archives permeated and fundamentally changed European culture. Archives were compiled and maintained by peasants and kings, merchants and churchmen, and conceptions of archives were as diverse as those who used them. The complex, demanding job of the archivist was just as variable: archivists might serve as custodians, record-k...

A leading Catholic historian tells the fascinating story of how the Jesuits shaped the modern worldSince its founding by Ignatius of Loyola in 1540, the Society of Jesus—commonly known as the Jesuits—has played a critical role in the events of modern history.In A Concise History of the Jesuits, Markus Friedrich, a leading historian of the Jesuits in academia, tells the story of the Society of Jesus from its founding to the papacy of Francis, the fi...

This book provides an overview of the available evidence surrounding immunotherapy in gastrointestinal cancers, and discusses its future place in clinical practice.Immunotherapy has celebrated some astonishing therapeutic successes in a variety of cancer types and is becoming increasingly relevant in daily clinical practice. Currently, the predominant class of immunotherapeutic drugs is the so-called checkpoint inhibitors, which disengage the physiological brakes on the immune syst...